The Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Evacetrapib Administered as Monotherapy or in Combination With Statins

Evacetrapib is a novel cholesteryl ester transfer protein (CETP) inhibitor currently being evaluated in a late-stage cardiovascular outcome trial. Using population-based models, we analyzed evacetrapib concentration data along with high-density lipoprotein cholesterol (HDL-C) and low-density lipopro...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Friedrich, S, Kastelein, J J P, James, D, Waterhouse, T, Nissen, S E, Nicholls, S J, Krueger, K A
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2014
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910017/
https://ncbi.nlm.nih.gov/pubmed/24452615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/psp.2013.70
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы